PhD, 2010, University of Illinois at Urbana-Champaign
BA, 2000, Rice University
NIH Director’s New Innovator Awardee
Nanotechnology offers some of its greatest potential contributions in the precise control of molecular binding events and the transduction of binding phenomena. The Heller lab is committed to employing this potential for two crucial pursuits: the early detection of cancer, and the innovative treatment of metastatic disease.